title: Primary malignant melanoma of the esophagus treated by esophagectomy and adjuvant dendritic-cell therapy.
authors.forename: Masahiro
authors.initials: M
authors.lastname: Asakage
authors.forename: Joji
authors.initials: J
authors.lastname: Kitayama
authors.forename: Nelson H
authors.initials: NH
authors.lastname: Tsuno
authors.forename: Yasuhiro
authors.initials: Y
authors.lastname: Komuro
authors.forename: Shoichi
authors.initials: S
authors.lastname: Kaisaki
authors.forename: Nobukazu
authors.initials: N
authors.lastname: Hori
authors.forename: Hirokazu
authors.initials: H
authors.lastname: Nagawa
authors.forename: Nelson H
authors.initials: NH
authors.lastname: Tsuno
authors.forename: Nobukazu
authors.initials: N
authors.lastname: Hori
authors.forename: Koki
authors.initials: K
authors.lastname: Takahashi
mesh_terms: D000276:Adjuvants, Immunologic; D001707:Biopsy, Needle; D003713:Dendritic Cells; D004938:Esophageal Neoplasms / Q000175:diagnosis* / Q000628:therapy*; D016629:Esophagectomy / Q000379:methods; D004945:Esophagoscopy; D005500:Follow-Up Studies; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008545:Melanoma / Q000175:diagnosis* / Q000628:therapy*; D008875:Middle Aged; D009367:Neoplasm Staging; D018570:Risk Assessment; D016896:Treatment Outcome
chemical_list: D000276:Adjuvants, Immunologic